Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer's disease: current approaches and future perspectives.
Chakraborty S, Vishwas S, Harish V, Gupta G, Paudel KR, Dhanasekaran M, Goh BH, Zacconi F, de Jesus Andreoli Pinto T, Kumbhar P, Disouza J, Dua K, Singh SK. Chakraborty S, et al. Among authors: de jesus andreoli pinto t. Expert Opin Drug Deliv. 2024 Oct 13:1-22. doi: 10.1080/17425247.2024.2414768. Online ahead of print. Expert Opin Drug Deliv. 2024. PMID: 39397403 Review.
Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells.
De Rubis G, Paudel KR, Liu G, Agarwal V, MacLoughlin R, de Jesus Andreoli Pinto T, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. De Rubis G, et al. Among authors: de jesus andreoli pinto t. Toxicol In Vitro. 2023 Oct;92:105660. doi: 10.1016/j.tiv.2023.105660. Epub 2023 Aug 15. Toxicol In Vitro. 2023. PMID: 37591407
Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling.
Bhat AA, Gilhotra R, Singh Y, Sharma S, Jesus Andreoli Pinto T, Ferraz HG, Singh SK, Dua K, Gupta G. Bhat AA, et al. Among authors: jesus andreoli pinto t. Nanomedicine (Lond). 2023 Mar;18(7):583-587. doi: 10.2217/nnm-2023-0032. Epub 2023 May 17. Nanomedicine (Lond). 2023. PMID: 37194747 No abstract available.
Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems.
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, de Jesus Andreoli Pinto T, Chan Y, Liu G, Paudel KR, Hansbro PM, George Oliver BG, Dua K. Prasher P, et al. Among authors: de jesus andreoli pinto t. Chem Biol Interact. 2022 Sep 25;365:110048. doi: 10.1016/j.cbi.2022.110048. Epub 2022 Aug 4. Chem Biol Interact. 2022. PMID: 35932910 Review.
Tertiary Nanosystem Composed of Graphene Quantum Dots, Levofloxacin and Silver Nitrate for Microbiological Control.
Vieira TO, Ricci-Junior E, de Barros AODS, Rebelo Alencar LM, Ferreira MRS, de Jesus Andreoli Pinto T, Santos-Oliveira R, de Holanda Saboya Souza D. Vieira TO, et al. Among authors: de jesus andreoli pinto t. Recent Adv Drug Deliv Formul. 2022;16(3):234-240. doi: 10.2174/2667387816666220715121107. Recent Adv Drug Deliv Formul. 2022. PMID: 35850654
Hybrid molecules based on 1,3,5-triazine as potential therapeutics: A focused review.
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, de Jesus Andreoli Pinto T, da Silva MW, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Prasher P, et al. Among authors: de jesus andreoli pinto t. Drug Dev Res. 2020 Nov;81(7):837-858. doi: 10.1002/ddr.21704. Epub 2020 Jun 24. Drug Dev Res. 2020. PMID: 32579723 Review.
Targeting microRNAs using nanotechnology in pulmonary diseases.
Dua K, Chellappan DK, Singhvi G, de Jesus Andreoli Pinto T, Gupta G, Hansbro PM. Dua K, et al. Among authors: de jesus andreoli pinto t. Panminerva Med. 2018 Dec;60(4):230-231. doi: 10.23736/S0031-0808.18.03459-6. Panminerva Med. 2018. PMID: 30563304 No abstract available.
25 results